Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

ALCON INC.

(ALC)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

Alcon Inc. : The beginning of the move

07/30/2020 | 08:17am EDT
long trade
Stop-loss triggered
Entry price : 56.44CHF | Target : 60.4CHF | Stop-loss : 54.7CHF | Potential : 7.02%
Shares in Alcon Inc. have recently benefitted from a regain of interest by market participants. The technical chart pattern suggests a continuation of the upward movement.
Investors have an opportunity to buy the stock and target the CHF 60.4.
Alcon Inc. : Alcon Inc. : The beginning of the move
Summary
  • The company usually posts poor financials for mid or long term investments.
  • For a short-term investment strategy, the company has poor fundamentals.

Weaknesses
  • Stock prices approach a strong long-term resistance in weekly data at CHF 62.01.
  • The stock is close to a major daily resistance at CHF 62.38, which should be gotten rid of so as to gain new appreciation potential.
  • The company has insufficient levels of profitability.
  • Sales estimates for the next fiscal years vary from one analyst to another. This clearly highlights a lack of visibility into the company's future activity.
  • The company's enterprise value to sales, at 4.59 times its current sales, is high.
  • The company is not the most generous with respect to shareholders' compensation.
  • For the last four months, the sales outlook for the coming years has been revised downwards. No recovery of the group's activities is yet foreseen.
  • For the last twelve months, the trend in sales revisions has been clearly going down, which emphasizes downgraded expectations from the analysts.
  • For the last four months, earnings estimated by analysts have been revised downwards with respect to the next two years.
  • For the past year, analysts have significantly revised downwards their profit estimates.

ę MarketScreener.com 2020

Disclaimer: The information, charts, data, views, or comments provided by SURPERFORMANCE SAS are intended for investors who have the necessary knowledge and experience to understand and appreciate the information contained within. These items are disseminated for personal reference only. They do not constitute an offer or solicitation to buy or sell financial products or services, nor an investment advice.
The use of the information disseminated takes place under the investor's sole responsibility, without recourse against SURPERFORMANCE SAS. SURPERFORMANCE SAS will not be liable, whether in contract, in tort, under any warranty, for errors, omissions, improper investments, or adverse evolution of markets.

Financials (USD)
Sales 2021 7 927 M - -
Net income 2021 212 M - -
Net Debt 2021 2 416 M - -
P/E ratio 2021 120x
Yield 2021 0,16%
Capitalization 34 811 M 34 831 M -
EV / Sales 2021 4,70x
EV / Sales 2022 4,34x
Nbr of Employees 23 000
Free-Float 97,8%
Upcoming event on ALCON INC.
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 25
Average target price 78,07 $
Last Close Price 71,06 $
Spread / Highest target 24,1%
Spread / Average Target 9,88%
Spread / Lowest Target -9,75%
EPS Revisions
Managers and Directors
NameTitle
David J. Endicott Chief Executive Officer & Director
Timothy C. Stonesifer Chief Financial Officer & Senior Vice President
F. Michael Ball Chairman
Franck Leveiller Head-Global Research & Development
Sue-Jean Lin Chief Information Officer & Senior Vice President
Sector and Competitors
1st jan.Capitalization (M$)
ALCON INC.9.18%34 831
THE COOPER COMPANIES, INC.3.64%18 544
AUTEK CHINA INC.77.77%14 217
MENICON CO., LTD.14.40%2 440
PEGAVISION CORPORATION104.95%1 375
UNIVERSAL VISION BIOTECHNOLOGY CO., LTD.30.33%848